Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1158 | Male Reproduction | ECE2017

After 9 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (December 2016)

Pisoschi Matei

Aim: Has testosterone undecanoat 1000 mg injection (NebidoR; Bayer), 1/3month negative effect on prostate?Material and method: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) Patients: PSA analysis was done before treatment and recorded at T1 to T12 [2 weeks to 9 years] (see Pisoschi, this Congress). iii) Statistical analysis: Student test, simple correlation, multiple regression.<p class=...

ea0066p85 | Thyroid | BSPED2019

Paediatric Graves disease – management in a District General Hospital

Viswanath Vidya , Matei Cristina

Background: Graves disease is the most common cause of hyperthyroidism or thyrotoxicosis in children. The prevalance is 1 in 10 000 among children. It is important to reinforce the awareness amongst clinicians as patients can present with wide range of clinical symptoms. The range of presentations in our study included a child treated for one year for Attention Deficit Hyperactivity Disorder (ADHD) to a child who had diarrhoea and abdominal pain and presented as appendicitis i...

ea0039ep62 | Diabetes | BSPED2015

Frequency of Hypoglycaemia in Children and Young People’s Diabetes Clinic

Kyriacos Elizabeth , Matei Cristina

Background: Hypoglycaemia is a common complication of diabetes which causes great anxiety in patients and their families. Asymptomatic hypoglycaemia can be debilitating, especially in young children. All patients who attend Children and Young People (CYP) Diabetes Clinic have their blood glucose tested. If hypoglycaemia is identified (Blood Glucose less than 4 mmol/l), the local hypoglycaemia hospital policy should be followed by staff to provide safe and effective treatment.<...

ea0066p39 | Diabetes 3 | BSPED2019

Paediatric diabetic ketoacidosis (dka)-management in a district general hospital

Viswanath Vidya , Mallya Meera , Matei Cristina

Background: Diabetic ketoacidosis (DKA) can have significant morbidity and mortality in children and young people (CYP). Its management is very well standardised, based on National Guidance (National Institute of Clinical Excellence – NICE). In the UK, CYP DKA Guidelines have been reviewed in 2015 in order to reduce the risks of cerebral oedema. There have been concerns that the new recommended fluid management has the potential to increase the risk of acute kidney injury...

ea0066p42 | Diabetes 4 | BSPED2019

Newly diagnosed diabetes – incidence, presenting features and lessons learnt

Mallya Meera , Viswanath Vidya , Matei Cristina

Introduction: The incidence of type 1 diabetes (T1DM) is increasing, affecting approximately 1 in 500 children and young people (CYP) under 19 years of age. The diagnosis of diabetes, as well as initial investigations and management is standardised, based on national guidance. Initial education and management have huge importance for long-term glycaemic control. We review the practice in our hospital, to establish our compliance and any deviations from the guidelines. We also ...

ea0049ep1157 | Male Reproduction | ECE2017

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 9 years on hypogonadic patients. (December 2016)

Pisoschi Matei , Cristina Staicu Dana , Peretianu Dan

Aim: Re-analyzing (study starting in 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Materials and Methods: A. Patients: at onset 231 men with hypogonadism (median: 62 y). B. Distribution: by decade (starting with 20y); no =4, 14, 24, 61, 63, 49, 17, 1. C. TUD (NebidoR-Bayer) 1000 mg injected one/3 months i.m. D. Prostate volume (PV) appreciated by per-abdominal ultrasound: 3.5–5 MHz probe, ellip...

ea0039ep6 | Adrenal | BSPED2015

Not always CAH: urine steroid profiling in the investigation and diagnosis of adrenal causes of neonatal hyponatraemia and failure to thrive

Lam Francis , Matei Cristina , Rumsby Gill

A 1 month old baby boy presented at a local district general hospital with failure to thrive. He was born to non-consanguineous Eastern European parents, with an 18 month old healthy sister. The term birth was unremarkable, with nil of note from the antenatal history. Initial clinical examination revealed a slightly low but stable blood pressure for age, but was otherwise normal.Investigations: Biochemistry results showed low plasma sodium (125 mmol/l) a...

ea0032p662 | Male reproduction | ECE2013

Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012

Pisoschi Matei , Cristina Staicu Daniela , Peretianu Dan

Aim: To find if testosterone undecanoat 1000 mg injection (Nebido; Bayer-Schering) has a negative effect on prostate.Materials and methods: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) From over 175 patients to whom testosterone undecanoate 1000 mg, i.m. was administrated at 3 months, in the last 4 years, and to whom the prostatic volume was quantified (Journal of Sexual Medicine8</st...

ea0085p88 | Thyroid | BSPED2022

Hypothyroidism - unknown through the known

Seenivasan Abinaya , Tamilselvan Kanimozhi , Jones Stephanie , Matei Cristina

Hypothyroidism is a well-known cause of delayed puberty in children. But in rare instances, hypothyroidism can also be related to isolated menarche. The mechanism remains debatable whilst the overall incidence of the condition remains unknown.Case Report: 6-year girl presented to children’s emergency with 2 days history of vaginal bleeding. Mum reported her being intolerant to cold, constipated and faltering growth compared to her twin sister. Her s...

ea0063p301 | Reproductive Endocrinology 1 | ECE2019

After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)

Pisoschi Matei , Staicu Dana Cristina , Peretianu Dan , Oprisan Bogdan

Aim: Has testosterone undecanoat 1000 mg intramuscular injection (NebidoR; Bayer), 1 at 3month, negative effect on prostate? For this purpose, we appreciate the prostatic volume (see Pisoschi, this congress) and PSA (this study) in hypogonadic patients after testosterone injection up to 11 years.Material and method: A. PSA (ng/ml) was done in Bucharest accredited laboratories.B. Patients: PSA analysis was done before tre...